GlassScriptPhysician profile
Meghan Powers
NPI 1639655509
$1,546.98
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $593 · 2022: $777 · 2023: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $177.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $285.22 | 2021-2023 | Lifevest |
| Merck Sharp & Dohme LLC | $221.24 | 2021-2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $196.89 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $142.10 | 2021-2023 | Farxiga |
| Amgen INC. | $109.48 | 2021-2022 | |
| Kestra Medical Technology Services, INC. | $95.14 | 2022-2023 | Assure Wcd |
| Philips North America LLC | $92.68 | 2022 | |
| Pfizer INC. | $91.36 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $89.60 | 2021-2023 | Opdualag |
| Boston Scientific Corporation | $70.00 | 2021-2023 | Watchman Access System |
| Bayer Healthcare Pharmaceuticals INC. | $42.93 | 2021-2022 | |
| Abiomed | $23.16 | 2022 | |
| Novo Nordisk INC | $22.03 | 2022 | |
| Sanofi-Aventis U.S. LLC | $21.14 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $17.22 | 2023 | Uptravi, Opsumit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.02 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Powers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.